- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | SENSETIME-W Launches AI Solution for Professional IVD Scenarios | ||
| Fr | Cathay's AHK Completes Fleet Upgrade, Now Operates 14 A330F Freighters | ||
| Fr | M Stanley Drops TRAD CHI MED's TP to HKD1.6, Rating Underweight | ||
| Fr | M Stanley Raises Microsoft TP to US$530 as Gen AI Drives Azure Growth | ||
| Fr | BofAS Favors Copper Most in 2H, Downgrades XINYI SOLAR to Neutral | ||
| Fr | HSI Closes Midday at 24,309, Down 15 pts; HSTI Closes Midday at 5,352, Up 7 pts; XIAOMI Up over 4%; CITIC FAMC, KINGBOARD HLDG, MMG, CHINFMINING, TG SMART ENERGY Hit New Highs | ||
| Fr | M Stanley: XIAOMI-W YU7 Successful; TP HK$62; Overweight Recommended | ||
| Fr | HSBC Research Adds BANK OF E ASIA TP to $13.9, Rating Buy | ||
| Fr | M Stanley Cuts BUD APAC's TP to HKD9.5, Lowers 2025 Earnings Forecast by 9% | ||
| Fr | Citi: YU7 Launch May Prompt Tesla, XPENG-W to Further Cut Car Prices | ||
| Fr | M Stanley Predicts CHINA OVERSEAS Shr Price to Rise in Next 30 Days | ||
| Fr | «HIBOR»Latest HIBOR | ||
| Fr | Citi Expects Positive Reaction to XIAOMI-W Stock Price from YU7 Orders; Rating Buy | ||
| Fr | CICC: LI NING Receives Stake Increase from Controlling Shareholder, Supporting Stable Biz & Mgmt Progress | ||
| Fr | Nomura: BEIGENE Hikes No. of Preclinical Studies to 85 This Yr, Conducting 96 Clinical Trials | ||
| Fr | G Sachs: Probability of Major Crude Oil Supply Disruption Has Nosedived; Mkt Expects Large Inventory Builds from Fall | ||
| Fr | Nomura Adds LAOPU GOLD's TP to HKD1,023, Envisions Sales Growth Momentum to Persist into 2H25 | ||
| Fr | CN AMC Popular as CHINA CINDA Soars 23% on Major Deal; CITIC FAMC Sets ~6-yr High | ||
| Fr | G Sachs Raises XIAOMI-W's TP to HKD69; YU7 Launch Strengthens Leadership in CN Premium Auto Mkt | ||
| Fr | Macquarie Sees XIAOMI-W's YU7 Pricing Attractive, Expects Strong Pre-sale Data to Push Up Shr Price | ||
| Fr | G Sachs Expects BUD APAC 2Q EBITDA to Drop 12.6%, Cuts TP to $9 | ||
| Fr | CITYCHAMP Once Rockets 98% Before Gains Narrow; Trading Vol. Hikes | ||
| Fr | G Sachs: CATL Product Mix Improves, Benefiting from YU7 Launch; Rating Kept at Buy | ||
| Fr | CHINA TRAVEL HK Tumbles 10% After 32% Rally in Early Session; Biz Portfolio Review Underway but No Decision Made Yet | ||
| Fr | UBS Initiates Coverage on 3SBIO w/Rating Buy, TP $30; Key Licensing Agreement Validates R&D Capabilities |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .